Corporate Perspective, Information Systems
Thursday, October 4, 2018
by
Christine Cheng, PharmD
Medication names that look or sound similar are problematic because they can be easily confused with each other. Examples of look-alike, sound-alike (LASA) medication names include hydralazine-hydroxyzine, Keflex-Keppra, metronidazole-metformin, Zyprexa-Zyrtec and Actonel-Actos. At least one out of every 1,000 prescriptions in the United States is associated with a wrong-medication error, and name confusion is thought to be a key cause.
Read more...
Comments (0)
Corporate Perspective, Transformational Change, Information Systems
Monday, June 25, 2018
by
Charles Lee, MD
Patient engagement is defined by the Center for Advancing Health as “actions individuals must take to obtain the greatest benefit from the health care services available to them.” Certainly, such engagement is essential when it comes to one of the most important patient actions of all: taking medications. After all, as a Yoruba proverb says: “Medicine left in the bottle can’t help.”
Read more...
Comments (0)
Corporate Perspective, Transformational Change, Information Systems
Monday, February 5, 2018
by
Lee Ann McWhorter
Today’s medical device data is far more likely to be inaccurate, unclear, and unreliable. And that’s entirely unacceptable when you consider the vast range of users who rely on this knowledge to identify, source, manage, document, track, and bill for millions of device options.
Read more...
Comments (0)
Corporate Perspective, Information Systems, Transformational Change
Wednesday, January 3, 2018
by
Josh Young
We recently interviewed FDB's Director of Software Engineering Joshua Young about the application of artificial intelligence in healthcare. What follows are highlights from that interview.
Read more...
Comments (2)
Corporate Perspective, Information Systems
Tuesday, August 22, 2017
by
Helena Dummler, PharmD
Our society’s focus on natural and organic products that promote health has directed scrutiny to chemicals used as preservatives. What is the issue with preservatives?
Read more...
Comments (1)